TRDA Nilai Total Aset Perusahaan Entrada Therapeutics Inc.

TRDA (Entrada) - tandha merek perusahaan

This daily price action for Entrada Therapeutics (TRDA) on GURU.Markets reflects total assets amounting to 373.80. The business relies on a universal method for transporting biologics into cells, which streamlines the mass production of numerous drugs. Payments from global behemoths for access to this technology are currently supporting the growth. However, success is complicated by development challenges and a dependence on new investments.

TRDA (Entrada Therapeutics) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 30.10.2026

Rincian analitis lan laporan data perusahaan Entrada (TRDA)

- nilai pasar lan prakiraan target analis:
Rega saham entradatx.com|TRDA - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Entrada Therapeutics, Inc|TRDA - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Akuntansi Saham Entrada Therapeutics|TRDA - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku entradatx.com|TRDA - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Entrada Therapeutics|TRDA - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Entrada Therapeutics, Inc|TRDA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Entrada Therapeutics, Inc|TRDA - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Entrada Therapeutics|Rasio likuiditas darurat entradatx.com
- indikator pendapatan resik lan kelipatan nilai:
TRDA - Bathi resik
Pambiji fundamental:Entrada Therapeutics
Produk sing diprodhuksi Entrada Therapeutics

Entrada Therapeutics investors are anticipating the monetization of the EEV platform amid stringent FDA oversight. Total assets, calculated inversely via ROA, measure the aggregate resource potential and financial stability of the business. According to the total asset calculation on GURU.Markets, the current value is 373.80. This volume of capital ensures the protection of intellectual property and covers the costs of complex clinical trials for neurological drugs.

Pesaing wigati

jazzpharma.com (JAZZ) - Total Aset Perusahaan|Aset Agregat Perusahaan Cytokinetics, Incorporated|PTC Therapeutics Inc - Nilai Total Aset Perusahaan|Total Aset Perusahaan SRRK|CNTA (Centessa Corp) - Nilai Agregat Aset|Total Aset Perusahaan DYN (Dyne Therapeutics, Inc.)|Total Aset Perusahaan edgewisetx.com EWTX|RAPP - Aset Agregat Perusahaan|Nilai Agregat Aset ALMS (Alumis Inc)|Kempharm (ZVRA) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Contineum Corp|LRMR (Larimar Therapeutics) - Total Aset Perusahaan|Total Aset Perusahaan Capricor|Gunggung Aset Perusahaan PTHS (Channel Therapeutics Corp)|MNOV (medicinova.com) - Nilai Agregat Aset|Aset Agregat Perusahaan Serina SER|BTAI: Total Aset Bisnis|ProMIS - Total Aset Perusahaan|Aset Perusahaan Apimeds Pharmaceuticals|AEON (aeonbiopharma.com) - Gunggung Aset Perusahaan|NLS Pharmaceutics (NLSP) - Total Aset Perusahaan|Aset Agregat Perusahaan Bionomics Ltd.|HUGE: Nilai Agregat Aset|Aset Agregat Perusahaan Reata Pharmaceuticals (RETA)